New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareEnclomiphene vs AICAR

Enclomiphene vs AICAR

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Enclomiphene
Anti-Aging & LongevityFat Loss & Metabolic
AICAR
Summary
Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that stimulates endogenous testosterone production by blocking estrogen negative feedback on the hypothalamus and pituitary. Unlike TRT, it restores testosterone while preserving or increasing sperm production and testicular volume.
AICAR is a cell-permeable AMP analog that activates AMPK (AMP-activated protein kinase) — the master metabolic switch that triggers fat burning, mitochondrial biogenesis, and adaptations normally only achieved through exercise. It has been called the 'exercise in a pill' compound.
Half-Life
5-7 days (long half-life; accumulates)
~2–3 hours
Admin Route
Oral
SubQ, IV
Research
Typical Dose
12.5-25 mg per day
25–50 mg
Frequency
Once daily or every other day
3–5 times per week
Key Benefits
  • Restores testosterone to normal range without exogenous androgen administration
  • Preserves or increases sperm production and fertility
  • Maintains testicular volume (unlike TRT which causes testicular atrophy)
  • LH and FSH levels rise, indicating intact HPG axis function
  • Option for hypogonadal men desiring fertility
  • Oral administration (no injection required)
  • AMPK activation mimics aerobic exercise adaptations
  • Increased fat oxidation and endurance
  • Mitochondrial biogenesis (PGC-1alpha)
  • Improved insulin sensitivity and glucose metabolism
  • Anti-inflammatory effects
  • Potential cardiac protection during ischemia
  • Synergistic with actual exercise training
  • Reduces hepatic glucose production
Side Effects
  • Visual disturbances (rare but class-related SERM effect)
  • Mood changes or irritability
  • Hot flashes
  • Elevated estradiol in some users
  • +2 more
  • Hypoglycemia risk
  • Lactic acidosis at high doses (animal data)
  • Injection site irritation
Stacks With